Doctor profile · Federal record

Dr. Roy Avalos, M.D.

Cardiovascular Disease Physician (CMS: Cardiovascular Disease (Cardiology)) · Encinitas, CA

  • NPI 1154399632
  • Accepts Medicare
  • 29 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
320 Santa Fe Dr, Suite 204
Encinitas, CA 920245138
(760) 944-7300
fax (760) 634-6564

Credentials & registration

NPPES · NUCC
NPI registered
March 2006 — 20 yrs on file
Profile last updated
March 9, 2017
Year of graduation
1997 — 29 yrs since
Specialty taxonomy
207RC0000X — NUCC code
State license (1)
California #A68893

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1154399632. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,293
Distinct HCPCS
10
Medicare allowed
$606,635
HCPCS Description Services Patients Avg allowed
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 526 263 $95
J2785 Injection, regadenoson, 0.1 mg 492 123 $52
99215 Established patient office or other outpatient visit, 40-54 minutes 467 344 $190
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function 347 338 $71
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 335 160 $123
93015 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician 275 275 $68
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function 269 266 $215
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect 268 268 $504
99214 Established patient office or other outpatient visit, 30-39 minutes 255 228 $137
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes 169 162 $179

In context: peer comparison

Among 8 peers in this city , average services per provider: 223. This provider delivers 19× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,161
Transactions
64
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Inari Medical, Inc. 7 $419.42
Penumbra, Inc. 2 $307.06
Amgen Inc. 5 $289.25
Medtronic, Inc. 3 $203.03
Merck Sharp & Dohme LLC 7 $183.71
Novo Nordisk Inc 3 $162.20
Novartis Pharmaceuticals Corporation 8 $157.04
HEARTFLOW, INC. 4 $153.91
AstraZeneca Pharmaceuticals LP 3 $147.27
Esperion Therapeutics, Inc. 6 $141.35
iRhythm Technologies, Inc. 1 $119.90
PFIZER INC. 3 $113.73
Kestra Medical Technology Services, Inc. 1 $112.48
ABIOMED 4 $103.79
CVRx, Inc. 7 $80.91

By nature of payment

Food and Beverage
$3,161

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,887
Patients
923
Total drug cost
$581,033
Drug Type Claims Patients Total cost
Atorvastatin Calcium Generic 385 112 $5,365
Eliquis (Apixaban) Brand 342 95 $432,093
Amlodipine Besylate Generic 266 84 $2,688
Clopidogrel (Clopidogrel Bisulfate) Brand 237 76 $4,826
Losartan Potassium Generic 227 74 $4,354
Metoprolol Succinate Generic 226 79 $4,366
Furosemide Generic 177 75 $1,776
Lisinopril Generic 171 52 $2,546
Rosuvastatin Calcium Generic 167 60 $6,669
Carvedilol Generic 149 47 $2,151

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Roy Avalos's medical specialty?
Dr. Roy Avalos practices Cardiovascular Disease Physician in Encinitas, CA.
Where does Dr. Roy Avalos practice?
Dr. Roy Avalos practices at 320 Santa Fe Dr, Encinitas, CA 920245138. Office phone: 7609447300.
What is Dr. Roy Avalos's NPI?
Dr. Roy Avalos's National Provider Identifier (NPI) is 1154399632, issued by NPPES.
Does Dr. Roy Avalos accept Medicare assignment?
Yes. Dr. Roy Avalos accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Roy Avalos commonly perform?
Top Medicare-reported procedures in 2023: Technetium tc-99m tetrofosmin, diagnostic, per study dose (HCPCS A9502); Injection, regadenoson, 0.1 mg (HCPCS J2785); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.